Frontiers | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy | Microbiology
Human papillomavirus (HPV)-induced cervical cancer is a major health issue among women from the poorly/under-developed sectors of the world. It accounts for a high-mortality rate because of its late diagnosis and poor prognosis. Initial establishment and subsequent progression of this form of cancer are completely dependent on two major oncogenes E6 and E7, which are expressed constitutively leading to tumorigenesis. Thus, manipulation of these genes represents the most successful form of cervical cancer therapy. In the present article, information on structural, functional, and clinical dimensions of E6 and E7 activity has been reviewed. The genome organization and protein structure of E6 and E7 have been discussed followed by their mechanism to establish the six major cancer hallmarks in cervical tissues for tumor propagation. The later section of this review article deals with the different modes of therapeutics, which functions by deregulating E6 and E7 activity. Since E6 and E7 are the biomarkers of a cervical cancer cell and are the ones driving the cancer progression, therapeutic approaches targeting E6 and E7 have been proved to be highly efficient in terms of focused removal of abnormally propagating malignant cells. Therapeutics including different forms of vaccines to advanced genome editing techniques, which suppress E6 and E7 activity, have been found to successfully bring down the population of cervical cancer cells infected with HPV. T-cell mediated immunoth...
;import{g as i,s as o,r as s,e as a,a as u,h as l,b as c,i as h,t as f,c as d,d as p,f as m,j as g,k as y,l as b,K as v,_ as w,S as E,m as _,o as C,w as M,n as S,p as O,q as B,u as D,v as I,x as T,y as x,z as R,A as N,U as k,H as F,B as L,C as P,Y as U,D as j,E as q,F as z,G as $,I as V,J as H,L as W,M as G,N as K,O as Z,P as Y,Q as J,R as X,T as Q,V as AA,W as eA,X as tA,Z as rA,$ as nA,a0 as iA,a1 as oA,a2 as sA,a3 as aA,a4 as uA,a5 as lA,a6 as cA,a7 as hA,a8 as fA,a9 as dA,aa as pA,ab as mA,ac as gA,ad as yA,ae as bA,af as vA,ag as wA,ah as EA,ai as _A,aj as CA,ak as MA,al as SA,am as OA,an
Explore this link on the map →related reading
- Frontiers | Principles and Practice of Explainable Machine Learningfrontiersin.org
- Frontiers | Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Groupfrontiersin.org
- Frontiers | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Updatefrontiersin.org
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Frontiers | A Bayesian model for chronic painfrontiersin.org
- Frontiers | Why Harmless Sensations Might Hurt in Individuals with Chronic Pain: About Heightened Prediction and Perception of Pain in the Mindfrontiersin.org
- Frontiers | Breastfeeding experiences and women's self-concept: Negotiations and dilemmas in the transition to motherhoodfrontiersin.org
- Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- Frontiers | Antigen Cross-Presentation by Macrophagesfrontiersin.org
- Prl Journalwritewithpearl.com
- Frontiers | The Role of NK Cells and Innate Lymphoid Cells in Brain Cancerfrontiersin.org
- Frontiers | Organic Molecules in Interstellar Space: Latest Advancesfrontiersin.org